SILVER-MODIFIED MONTMORILLONITE IN THE TREATMENT OF PATIENTS WITH AN INFECTED WOUND
Table 1 - Cytological studies of the dynamics of the reparative process of the wounds
Indicators | Upon admission | 7th day | 14th day | |||
Main | Control | Main | Control | Main | Control | |
Number of white blood cells | 66.7 ± 3.2 | 70.1 ± 2.8 | 38.6 ± 2.8 | 52.3 ± 2.2* | 1.2 ± 0.05 | 16.8 ± 2.6* |
Proportion of destroyed leukocytes,% | 70.2 ± 2.8 | 72 ± 3.2 | 58.2 ± 2.8 | 60.2 ± 2.1 | 0 | 56.2 ± 4.6* |
Cells, % | ||||||
neutrophils | 80.6 ± 3.2 | 78.9 ± 3.2 | 58.5 ± 2.8 | 76.2 ± 1.8* | 2.1 ± 0.08 | 16.3 ± 2.8 |
eosinophils | 0.99 ± 0.05 | 0.88 ± 0.07 | 0.86 ± 0.07 | 0.9 ± 0.07 | 0.86 ± 0.06 | 0.67 ± 0.1 |
lymphocytes | 2.2 ± 0.6 | 2.1 ± 0.7 | 5.6 ± 0.7 | 2.21 ± 0.8* | 16.3 ± 2.1 | 4.1 ± 1.0* |
polyblasts | 7.2 ± 0.3 | 8.6 ± 1.1 | 13.6 ± 1.8 | 10.2 ± 0.9* | 16 ± 1.6 | 11.2 ± 1.2* |
macrophages | 1.2 ± 0.08 | 1.3 ± 1.0 | 8.1 ± 0.72 | 3.9 ± 0.8* | 14.2 ± 2.2 | 6.6 ± 1.6* |
fibroblasts | 0.6 ± 0.08 | 0.8 ± 0.05 | 2.46 ± 0.17 | 1.2 ± 0.2* | 4.6 ± 1.8 | 2.2 ± 0.6* |
multicore cells | 0.03 ± 0.01 | 0.038 ± 0.01 | 0.05 ± 0.01 | 0.04 ± 0.01 | 0.06 ± 0.01 | 0.07*0.02 |
epithelium | 0 | 0 | units | 0 | cell groups | cell groups |
* – the difference is statistically significant, p < 0.05